Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 75, Issue 1
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical and epidemiological research
Extended report
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)
Online download statistics by month:
Online download statistics by month: June 2015 to October 2024
Abstract
Full
Pdf
Jun 2015
1639
118
276
Jul 2015
361
57
72
Aug 2015
178
51
60
Sep 2015
158
57
42
Oct 2015
91
42
26
Nov 2015
127
35
43
Dec 2015
669
60
167
Jan 2016
566
62
129
Feb 2016
283
46
58
Mar 2016
220
49
63
Apr 2016
237
46
54
May 2016
172
51
63
Jun 2016
159
47
35
Jul 2016
124
27
25
Aug 2016
127
23
31
Sep 2016
147
40
41
Oct 2016
129
40
36
Nov 2016
120
50
47
Dec 2016
133
41
104
Jan 2017
126
40
35
Feb 2017
178
58
33
Mar 2017
138
72
28
Apr 2017
140
45
30
May 2017
96
63
28
Jun 2017
134
40
25
Jul 2017
207
22
24
Aug 2017
201
29
26
Sep 2017
190
38
20
Oct 2017
239
26
17
Nov 2017
258
30
20
Dec 2017
249
30
12
Jan 2018
267
32
29
Feb 2018
242
30
24
Mar 2018
245
39
20
Apr 2018
306
47
17
May 2018
244
37
24
Jun 2018
240
34
20
Jul 2018
232
21
9
Aug 2018
194
44
16
Sep 2018
190
39
18
Oct 2018
182
21
12
Nov 2018
178
27
22
Dec 2018
168
8
8
Jan 2019
148
30
26
Feb 2019
165
21
11
Mar 2019
186
34
17
Apr 2019
157
16
9
May 2019
155
25
15
Jun 2019
122
19
12
Jul 2019
179
21
13
Aug 2019
131
15
10
Sep 2019
117
25
11
Oct 2019
113
22
21
Nov 2019
171
26
22
Dec 2019
299
47
23
Jan 2020
147
34
24
Feb 2020
161
21
7
Mar 2020
135
28
8
Apr 2020
144
29
14
May 2020
142
21
10
Jun 2020
166
24
12
Jul 2020
146
35
7
Aug 2020
124
25
9
Sep 2020
184
25
8
Oct 2020
187
36
14
Nov 2020
201
32
15
Dec 2020
174
19
6
Jan 2021
205
23
16
Feb 2021
197
23
16
Mar 2021
287
31
19
Apr 2021
128
18
10
May 2021
114
19
12
Jun 2021
24
18
11
Jul 2021
30
22
11
Aug 2021
22
18
5
Sep 2021
26
24
12
Oct 2021
260
17
11
Nov 2021
253
24
19
Dec 2021
214
12
7
Jan 2022
144
17
8
Feb 2022
143
8
1
Mar 2022
355
17
16
Apr 2022
202
14
6
May 2022
218
22
2
Jun 2022
209
16
5
Jul 2022
236
23
7
Aug 2022
246
11
4
Sep 2022
229
26
8
Oct 2022
273
32
18
Nov 2022
298
29
16
Dec 2022
197
23
7
Jan 2023
212
13
3
Feb 2023
390
16
10
Mar 2023
465
23
11
Apr 2023
341
73
12
May 2023
294
25
8
Jun 2023
246
15
8
Jul 2023
235
24
6
Aug 2023
135
18
6
Sep 2023
345
31
11
Oct 2023
572
23
6
Nov 2023
955
30
3
Dec 2023
333
38
7
Jan 2024
248
34
11
Feb 2024
233
22
21
Mar 2024
201
23
14
Apr 2024
256
27
10
May 2024
294
19
7
Jun 2024
173
22
6
Jul 2024
409
31
21
Aug 2024
192
17
12
Sep 2024
197
20
11
Oct 2024
204
13
5
Total
25778
3488
2669
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?